Archive for February, 2012

Landfill Contaminated With Asbestos

Elbert County in Denver, CO has a unique asbestos abatement project to tackle – that of a public landfill and trash compactor site. The site has historically been used to dispose of roofing and building materials, much of which was from before the mid 1970’s when buildings were routinely constructed with an abundance of asbestos. The landfill has been the primary dumping site for such rubbish but then it is compacted into bundles and shipped off to another landfill.

Concern about asbestos at the site arose when a backhoe company began excavating the grounds in preparation to remove an old missile silo. Local residents in the area called in complaints to authorities that contaminants were being spread by the excavation. Subsequent soil tests and tests to the debris at the landfill showed the presence of asbestos. No charges were filed because the asbestos had not yet gone airborne, but rather was contained to the landfill site.

Upon learning of the presence of asbestos among other environmental contaminants, the excavating was ceased and the area was covered, pending professional asbestos abatement services.

Cory Stark, director of Elbert County Emergency Management determined that the backhoe company, Backhoe Services, was operating without having tested the soil first and without a formal contract with the city. As reported by the Denver Post, Backhoe Services could not be reached for comment.

Stark asserts that there has been no danger to local residents so far as the toxins have been contained. Still, local residents have remained cautious and concerned. They are now taking their trash and debris to an alternate dump site.

Asbestos diseases such as lung cancerasbestosis, and mesotheliomaare the unfortunate result of asbestos exposure. If you have been diagnosed with an asbestos-related disease, contact a mesothelioma lawyer at Sokolove Law today for a free consultation.

Asbestos

More Congressional Interest in Asbestos Trust Funds

If you read the last article we posted about asbestos trust funds, you’ll remember the clever hammock analogy used to describe what they are. If you didn’t read it, you can do so here.

Now, the Government Accountability Office (GOA) – a sort of congressional watchdog group that keeps an eye on government spending of taxpayer dollars – has published a report that reveals the somewhat secretive system of asbestos trust fund payouts.

The report looked at 52 asbestos trust funds that have paid out over 3,000,000 claims for a total of about $17.5 billion. The investigation was prompted by the fact that these asbestos trust funds don’t publish details about their activities, yet do make general information available. Attorneys representing asbestos companies or defendants — in asbestos lawsuits filed by mesothelioma victims – raised a stink about the secrecy of the details and implored congress to get involved. The investigation proceeded to determine if, in fact, these asbestos trust funds were keeping details secret.

The investigation revealed only “one trust’s financial report contained claimant names and amounts paid to these individuals.”

The defendants in asbestos lawsuits have been the critics of asbestos trust fund secrecy. They allege that asbestos lawyers and mesothelioma law firms oversee the operation of these asbestos trust funds to prevent them from revealing how much their clients have been paid. This, they further allege, allows some asbestos attorneys to file claims with multiple trusts that could contradict each other.

The GAO report stated that 98% of asbestos trust fund claims go through what is called an expedited review process, which requires a claim form and some documentation that asbestos exposure happened. Perhaps the lawyers representing the asbestos companies want mesothelioma victims to have to go through much more than that to get the compensation they deserve?

According to the report, 65 percent of asbestos trust funds treat claims information as confidential and privileged. Defendants and insurers want the details to be available to them so they can reduce the value of the claims awarded to mesothelioma victims in court.

If you or someone you know has been diagnosed with mesothelioma and suspect it’s due to asbestos exposure, contact a mesothelioma attorneyat Sokolove Law for a free consultation. Also, write to your local congressman about keeping the details of asbestos trust fund settlements confidential and out of the hands of the asbestos companies

Asbestos

Mesothelioma Death Count Rising in Minnesota

In a health study of Taconite Workers in Iron Range, Minnesota, the number of citizens who died of mesothelioma is higher than they reported a year ago – up from 63 to 82. Researchers found the additional nine cases by checking death records of former residents who moved out of state.

The University of Minnesota is responsible for the study, which started in 2008 and will wrap up as early as mid-2012. So far, results indicate that the rate at which residents have contracted mesothelioma is much higher than it should be.

Mesothelioma is a rare and fatal cancer, caused primarily by exposure toasbestos fibers, which often takes 30 years or more after exposure to show up.

Exactly how Iron Range residents have been exposed to asbestos is a mystery. Speculation includes one theory that workers handled asbestos in certain products then carried it home. Another theory is that processing taconite rock (a low-concentrate iron ore that has been mined and processed in Minnesota since the 1950s) releases asbestos fibers from within the rock into the air. The mystery is what provoked the $4.9 million health study, which was approved by state lawmakers in 2008.

Researchers have collected data on people who worked in mining as far back as the 1920’s. So far, the study shows that out of about 46,000 taconite workers who ever worked in the industry, 1,681 developed some sort of lung cancer.

Currently, the results from more than 2,000 air samples taken over the last two years at Minnesota’s six operating taconite plants show safe dust levels. Asbestos levels are extremely low, according to the study. Silica concentration was found to be higher than acceptable in some cases.

Mesothelioma

International Mesothelioma Program New Research

The International Mesothelioma Program at Brigham and Women’s Hospital and Harvard Medical School in Boston continue to make progress in malignant mesothelioma research. The scientists and doctors involved with the project are looking for information that will lead to better adjuvant therapies for the rare and deadly disease. Adjuvant therapies are treatments given to help boost the effectiveness of other treatments. In the case of malignant mesothelioma, the term “adjuvant therapies” typically refers to treatments that are administered to patients after they have had tumors surgically removed.

In a recent study, scientists used mice to test potential adjuvant therapies. Human mesothelioma cells were introduced into the test mice, allowed to metastasize (to grow), then surgically removed. This procedure turned the mice into workable test subjects for testing ne mesothelioma adjuvant therapies.

One of the therapies researchers studied on the mice was “intracavitary chemotherapy,” which means applying the chemotherapy drug, paclitaxel, into the cavity of the body around the site where the tumor has been removed just prior to closing the incision. The results of this test on the test mice were encouraging.

In a report published in the Annals of Thoracic Surgery, “Paclitaxel-laded Expansile Nanoparticles in a Multimodal Treatment, Model of Malignant Mesothelioma,” the researchers state: “Treatment with [paclitaxel] improved overall survival in the setting of [the surgery], suggesting that [it] merits further evaluation for intracavitary drug delivery following the surgical resection of malignant mesothelioma.” What this means is that this particular adjuvant therapy may be successful in the survival of mesothelioma patients.

Advancements such as these are very important to patients of malignant mesothelioma, as the cancer is serious and fatal.

For those who have been diagnosed with mesothelioma cancer that can be linked to asbestos exposure caused by a product or former employer, you may be entitled to financial compensation. Contact an experiencedmesothelioma attorney to learn more about your rights, and to see if pursuing a mesothelioma settlement is in your best interest.

Mesothelioma

New Science Part Three Mesothelioma Genetic Link

It’s long been suspected that a person’s genetics play a role in determining susceptibility to the development of mesotheliomafollowing exposure to asbestos fibers. The suspicion caused the U.S. Department of Health and Human Services National Institutes of Health (NIH) to fund research that would discover this genetic link. As of August, 2011, the specific gene mutation was not only found, but identified to also trigger other types of cancer.

The culprit is the gene, BAP1. Not a very creative name, is it? Why not name genes after Greek gods and goddesses rather than assigning them boring codes made up of capital letters and numbers? The former would better match the mystical powers genes have to determine so much about a person from appearance to temperament to health and beyond. Anyway, the research showed that people with a mutation on the BAP1 gene are more susceptible to developing both mesothelioma cancer as well as melanoma cancer of the eye.

The upshot is that people who are exposed to asbestos are far more likely to develop mesothelioma if they have this mutation to BAP1. The research was funded by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by scientists at the University of Hawaii Cancer Center in Honolulu, and Fox Chase Cancer Center in Philadelphia. The study results were published in Nature Genetics and reported the outcome of tests within two U.S. families with a high incidence of mesothelioma and other cancers linked with BAP1 mutations.

The study’s co-leader,Dr. Joseph Testa, notes that “it appears likely that other genes, in addition to BAP1, will be found to be associated with elevated risk of mesothelioma.” In the study, every person in the two families who developed mesothelioma or melanoma of the eye did have mutations of the BAP1 gene. The research team went on to look at 26 additional people diagnosed with mesothelioma but with no family history of the disease and found that 25 percent of them also had the BAP1 mutations.

Dr. Michele Carbone, study co-leader and director of the University of Hawaii Cancer Center, says of the results: “Identifying people at greatest risk for developing mesothelioma, especially those exposed to dangerous levels of asbestos worldwide, is a task made easier by virtue of this discovery.”

This concludes our series on the newest science concerning mesothelioma. These findings are exciting and inspiring of hope that future diagnostic and treatment practices will help people with mesothelioma live longer, healthier lives. Hope is the message we choose to focus on this week following National Mesothelioma Awareness Week.

Mesothelioma

Mesothelioma New Science Series

In honor of National Mesothelioma Awareness Day, we’re launching a three-part blog series highlighting the newest scientific research regarding mesothelioma. New science has emerged in the last two years that may have significant implications for the future treatment ofmalignant mesothelioma. In this series, we will look at three important scientific breakthroughs that have the largest potential to affect the future of mesothelioma treatment.

In early 2010, results of a study were published in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine that proved the safety of a possible vaccine for mesothelioma.

In late 2010, Dr. Rachel Ostroff, the clinical research director of Somalogic Inc., presented results of an ongoing study at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development about new biomarkers she discovered for mesothelioma that would impact early diagnosis and provide insight into new therapies for the disease.

Just last month, NIH-funded research discovered a genetic link to mesothelioma.

History of Mesothelioma and Asbestos Exposure

As far back as the early 1900’s, cases of mesothelioma and lung cancerhave been linked to asbestos exposure. It wasn’t until 1970 with the United States Clean Air Act that the Environmental Protection Agency (EPA) was permitted to start regulating asbestos as a hazardous pollutant. With asbestos being more and more regulated in the United States over the past forty years, the rate of new mesothelioma diagnosesin the U.S. each year has risen steadily in men and sporadically in woman.

Currently in the United States, there are an estimated 2000 to 3000 new cases of mesothelioma diagnosed each year. The increase in incidence may be the result of lag time between asbestos exposure and diagnosis, which can be up to 50 years. For this reason, the number of new mesothelioma diagnoses is expected to continue to rise through the year 2020.

New Science – Mesothelioma Vaccine

The continued increase in the rate of mesothelioma diagnosis and the current lack of treatment options is what inspired researchers at the Erasmus Medical Center in the Netherlands to study new therapies. Immunotherapy, which stimulates the immune system to target and destroy cancer cells, had previously shown promise. Based on this previous research, Dr. Joachim G Aerts, a pulmonary physician at Erasmus Medical Center, set out to create a vaccine for mesothelioma. The vaccine, which uses a patient’s own dendritic cells (DC) with antigen from the patient’s tumor, was able to induce a T-cell response against mesothelioma tumors.

In other words, three out of ten patients with malignant pleural mesothelioma of the epithelial subtype showed signs of tumor regression and four others showed evidence of cytotoxicity against their own tumors after vaccination. There is much more work to be done before results can be irrefutably attributed to the vaccine and side effects can be minimized, but the study showed real promise.

Dr. Aerts says of the study: “We hope that by further development of our method it will be possible to increase survival in patients with mesothelioma and eventually vaccinate persons who have been in contact with asbestos to prevent them from getting asbestos related diseases.”

In the next post of this series, we’ll look at mesothelioma biomarkers and the implications they have for possible future treatments

Mesothelioma

Asbestos Trust Funds Scrutinized by Republicans in Congress

Imagine a hammock that more and more people keep piling into without anybody getting out. The weight would quickly become too burdensome to bear and, sagging with a tangle of limbs and torsos, the rope would break. That’s what companies whose livelihoods were once asbestosdependent are like. With billions paid in asbestos settlements each year, the financial strain of numerous personal injury lawsuits from employees exposed to asbestos is too much for any corporation to hold.

What’s best for both the injured employees seeking compensation as well as the companies themselves is for the hammock to hold, or at least have a safety net in place. That’s why more and more of those companies have filed for Chapter 11 bankruptcies to reorganize their assets and debts as well as put aside money for injured asbestos workers into what are known as asbestos bankruptcy trusts. More and more of these have been established as more and more companies have filed Chapter 11’s over the past two decades.

The only problem with asbestos bankruptcy trusts is that the asbestos workers who are ill from asbestos exposure — whether with asbestosis,mesothelioma, or some other type of asbestos-related cancer — don’t receive what they need and deserve, which is the full value of their settlements. The system was created to make asbestos claims easier to file, often requiring no more than a diagnosis and a form to fill out. Yet, the amount of money that actually makes it to the injured worker is typically less than one third the amount of the settlement, according to a study by the RAND Corporation.

Now, there are around 50 different asbestos bankruptcy trusts paying out billions in asbestos claims each year. However, there are still many solvent companies liable for asbestos exposure injuries. Mesothelioma lawsuits are being filed against these solvent companies as regularly as the spinning of a well-oiled wheel. The companies have lawyers scrambling for ways to limit their liability and avoid taking responsibility for the widespread tragedy of asbestos-related cancer and other illness. To that end, defense lawyers want access to detailed records from asbestos bankruptcy trusts, allowing them to see who is paid how much for what specific illness.

Lately, Republicans in congress are looking at the issue, deciding whether to make changes to these asbestos bankruptcy trusts. As reported by the National Law Journal, asbestos lawyers andmesothelioma attorneys argue that the corporate defense lawyers want this reform only to expose the spokes of that well-oiled wheel so that they can throw in sticks.

There is no telling how soon or in what way Republicans in Congress will act on this issue. Meanwhile, if you have mesothelioma or another asbestos-caused illness, you may have a claim against an existing or future asbestos bankruptcy trust. If you were exposed to multiple asbestos products that were manufactured by different bankrupt companies, you may actually qualify for compensation under several trusts.

Asbestos

FDA Sued Over Documents in Birth Defects Lawsuit

The Food and Drug Administration (FDA) has been hit with a lawsuit alleging it failed to turn over documents regarding the use and distribution of the morning sickness drug thalidomide despite repeated requests by attorneys who have filed a birth injury lawsuitagainst the companies involved with the drug.

Law360 (subscription required) reports the FDA is being sued for allegedly violating the Freedom of Information Act by failing to fulfill requests for records pertaining to a case against GlaxoSmithKline PLC and other drug companies. The underlying birth injury lawsuit alleges GlaxoSmithKline and other defendants withheld evidence proving that the morning sickness drug caused birth defects. The complaint, filed on behalf of 13 people who were born with severe birth defects, also claims thalidomide was distributed to more than 20,000 people by Smith Kline & French (the predecessor GlaxoSmithKline) despite the fact that the drug never received FDA approval.

If you or a loved one have been affected by medical negligence during the birth of a child, you may want to speak to a birth injury attorney about filing a birth injury lawsuit.

Birth Defects

Rare Birth Defects Connected to Painkillers

Women who take certain over-the-counter painkillers during the early stages of pregnancy are more likely to give birth to infants with rare birth defects, a new study suggests.

The study, which has been published in the American Journal of Obstetrics and Gynecology, shows that women who took painkillers such as naproxen (the drug used in Aleve) or aspirin during pregnancy were three times as likely to have children with birth defects such as amniotic band syndrome (a condition that leads to clubfoot) or anaphthalmiaand microphothalmia (conditions where children are born with abnormally small eyeballs, or no eyeballs at all), Reuters reported.

Additionally, the study found that the use of these painkillers early in one’s pregnancy increased the risk of spina bifida by 60 percent, and that the risk of developing a cleft palate increased from 30 to 80 percent.

In the study, interviews were conducted with 15,000 women who had given birth to babies with birth defects and 5,500 women who had given birth to babies without defects. The interviews included questions about any painkillers they ingested during the first stage of their pregnancies.

According to The Centers for Disease Control and Prevention, anophthalmia and microphthalmia occurs in one out of every 5,300 U.S. births. Amniotic band syndrome is even rarer, occurring in approximately one out of every in 10,000 births.

Co-author of the study Martha Werler noted that although the results do not prove that painkillers are the sole cause of these rare birth defects, they are a warning sign. She also recommended that further research be conducted.

If you or someone you know has a child who has been harmed by painkillers, you may be entitled to compensation. Contact Sokolove Law for a free legal consultation.

Birth Defects

Bank of America Class Action Lawsuit

Bank of America Class Action Lawsuit: Does globalization erode the nation state’s capacity to act? Are nation states forced to converge in their policies even if these should not correspond to the democratically expressed will of their electorates? How does government action change under conditions of globalization? Questions like these have featured highly not only in public political discussions in recent years, but also in academic discourse, prompting a multiplicity of contributions to a debate that is still ongoing. This book aims to make a further contribution to this debate by focusing on a specific policy area and tracing and analysing devel­opments there comparatively across four countries and an extended period of time. Its results make no claim to provide a general answer to the questions above; however, it is hoped that—taken together with those of similar studies in different policy areas, countries, and time spans—they may contribute to the mosaic that will ultimately give us a differentiated picture of the conditions under which politics, governments, and states act at the beginning of the twenty-first century.

From the outside and a monopoly of power within” (ibid.: 478). This def­inition, however, no longer complies with the realities of statehood in the developed liberal democracies of today. Pluralist and corporatist develop­ments have exacerbated the trend towards differentiation within the state, and increasing trans- and supranational linkages have replaced sovereignty with interdependence. As a consequence, the “post-war settlement” of the “golden age” is being challenged, as states struggle to find resources in the face of tax competition, set binding rules under conditions of increasing inter- and supranational legal norms, and provide material security for their citizens while losing influence on business decision-making (Leibfried and Zürn 2005; Hurrelmann et al. 2007). While the lowering and even abolition of tariff barriers has enabled states and their citizens to enjoy the fruits of growing welfare through increased economic exchange, the lowering and abolition of the borders of statehood that go with it may also have altered the situation for states and citizens alike, increasing vulnerability to outside influences beyond their control. Unable to protect its citizens, the state’s legitimacy may be threatened in the medium and long run. But decoupling from the economic integration that has been growing over the last couple of decades and that has now literally spread around the globe would be no less costly economically and politically—if it were feasible at all.

Much of the public and academic debate around these issues is linked to the term “globalization”. It has undergone an amazing career over the last two decades. There hardly seems to exist a facet of public life that cannot be linked to this term: be it domestic conflicts regarding the need for political reforms and the necessity of redesigning social security systems; structural economic change and the shift of economic power to the emerging economies of South and Southeast Asia; debates about the fairness of global trade or its increasing de-materialization; the threat to cultural diversity presented by global media power and tourism—all that is mentioned in one breath with “globalization”, even if that link is often more one of mashing things together than providing proper explanation.

For more information on Bank of America Class Action Lawsuit: follow us on our RSS Feeds.

Globalization, we can conclude, is no clearly defined concept, and, as the aforementioned examples demonstrate, its use in that long debate has var­ied from concentration on specifically economic phenomena to very general social effects on a global scale. Beyond the very general insight that globaliza­tion denotes a continuing process of accelerated and deepened economic, but also general social, interaction on a global scale between formerly politically independent units (from which mutual influence follows), little agreement exists concerning the characteristics of globalization. Whether it constitutes a process of a historically new quality or not; whether states caused it or whether markets are the dominant actors; whether the economic, the social, or the political sphere is the main area of concern; whether it is a development to be applauded or to be contested—all these questions remained unanswered.

A common thread running through these different classifications, however, is that the main dividing line separating positions is the question whether globalization is perceived as an event that fundamentally alters the conditions states act under or not. It is this question—does globalization diminish the nation state’s capacity to act?—that has been identified as the central focus of the whole debate by a number of authors (Berger 2000: 52; Gourevitch 2002: 313; Zürn 2002: 240) and is thus a consensus that has been emerging in this multifaceted debate in recent years. But whether this capacity to act is indeed under threat (and what consequences this would have for the self-conception of democratic governance) is again contested.

Those who see the state’s capacity to act threatened by globalization empha­size that conditions for economic policy have changed substantially over the course of the last three decades. After the Second World War, controls over movements of currency and goods had allowed the state to siphon off rents from capital owners to finance public and welfare state spending (Scharpf 1996). After the breakdown of the Bretton Woods system of fixed exchange rates and the demise of currency controls, however, states lost command over the setting of domestic interest rates to the international financial markets and had to yield to their “tyranny” (Eichengreen 1997). In the sphere of fiscal policy, the state’s room for manoeuvre was also strongly curtailed, since glob­alization enforced a shift of taxation from the (highly mobile) factor, capital, to the (less mobile) factor, labour. As a consequence, it was argued, states were faced with the unpalatable choice between either running permanent public deficits or facing a decline in international competitiveness due to excessive labour costs. Deregulation and transnationalization further reduced the capacity for active state policy, and in terms of welfare state measures, globalization would lead to cut-throat competition and a “race to the bottom”. Consequently, authors arguing for this position spoke of the “erosion” of the nation state (Hilpert 1994), its “retreat” (Strange 1996), or even its “end” (Ohmae 1995).

Information from other sources on Bank of America Class Action Lawsuit:

The emphasized that the development over the last decades was not as unique as claimed, and that global economic integration was at a similar level at the beginning of the twentieth century (Hirst and Thompson 1996). A number of studies also questioned whether the restriction of state capacity was quite as drastic as sometimes stated: they found that tax competition between states, caused by globalization and international capital mobility, were not quite as pronounced and negative as expected, and that therefore neither were the consequences for welfare systems. Rather, it was argued, these systems demonstrated a remark­able degree of resilience and a capacity for adaptation, and party political preferences for taxation and redistribution could still be implemented (Garrett 1998; Swank 2002). Furthermore it could be shown that the costs of welfare state interventions in the economy through taxation were often balanced by positive externalities such as a high level of social stability and a well-trained workforce—and that these advantages were also recognized and appreciated by the owners of highly mobile capital. As a consequence, authors from this group have tended to see state capacity in a more positive light, spoken of “new tasks” for the state (Sassen 1998) and declared the thesis of the powerless state a “myth” (Weiss 1998).

According to this, a country will tend to export goods with whose production factor it is relatively abundantly endowed, while it will tend to import such goods whose production factors are relatively scarce at home. The reason is that a relative abundance in capital will cause the capital-abundant country to produce capital-intensive goods more cheaply than a labour-abundant country. Building on this standard economic theory, Ronald Rogowski some time ago developed a political sci­ence model to explain the emergence of societal cleavages (Rogowski 1989). Starting from rather simple assumptions about the domestic political process and with the help of the Stolper-Samuelson theorem,9 Rogowski was able to put forward hypotheses about the effects of increasing economic openness in order to explain the different political developments, coalitions, and cleavages in late nineteenth-century Britain, Germany, and the United States. In work done collaboratively with Jeffry Frieden, Rogowski undertook a—plausible— extension of this model to the process of globalization (Frieden and Rogowski 1996). The authors strove to explain the policy preferences of the relevant domestic actors, the policies carried out, and the development of national political institutions, claiming that the power of an interest group to assert its preferences varies with its mobility—or rather that of its factor of produc­tion. An interest group that can more credibly threaten to exit will increase its negotiation power and will thus have its preferences implemented into policy. Globalization will therefore lead to government policy adapting to the interests of capital owners (the most mobile factor of production), and since this adaptation will take place everywhere, policy convergence is the result.

The degree of competition depends on the mobility of all factors of production. But it is not only the extent of taxation that influences yield expectations of capital—labour, social, and environmental regulations also play a part in this competition. Since regulations impose costs, firms will try to minimize such costs. Therefore (and with the same logic as in the case of taxation) equalization will be the result in these areas as well. Which direction this competitive equalization between states will take—a “race to the bottom” with a downward spiral of regulatory intensity and a convergence on the smallest common denominator, or a “race to the top” with escalating regulation as a consequence of competition—depends on a variety of factors and is not relevant in the present context.

Quite the contrary development as the consequence of external change is what other theoretical approaches would lead us to expect, which focus on the stability of specific national characteristics. According to these theories (which give special emphasis to differences in policy styles, the resilience of institutional arrangements, and the path dependence of decisions more gener­ally), continued or even increased diversity of policy outputs and institutional structures will be the likely result. One of the first analyses to take such a perspective was probably Andrew Shonfield’s book on “Modern Capitalism” (Shonfield 1965). Shonfield explained in his extensive empirical analysis the differences in economic policy between the United States, France, Britain, and the Federal Republic of Germany primarily with reference to the different attitudes with which national political and economic actors approached the economy. These atti­tudes, Shonfield stated, were largely based on culturally specific orientations deeply rooted in the national history. While differences between them were often small and diffuse, over time they amounted to a significant order of magnitude.

Our use of the term or terms Bank of America Class Action Lawsuit: is for descriptive purposes only. There is no relationship between the owners of this website and the maker of the product discussed in this post. Our use of the words Recall, Class Action Lawsuit and other similar words related to an event do not necessarily mean that this event has occurred. Refer to the website of the United States Food and Drug Administration for information on drug or medical device recalls. If a Class Action Lawsuit is formed in relation to the product discussed in this post we will provide that information at the time the Class Action is formed. A Class Action Lawsuit is not required to exist for you to file a lawsuit if you have been injured by the product discussed in this post.

To keep up to date on Bank of America Class Action Lawsuit: visit our site often.

Bank of America